NEWARK, NJ November 1, 2016 − A panel of the United States Court of Appeals for the Second Circuit today affirmed the dismissal of a Venezuelan surety’s complaint seeking $12 million from Walsh’s client, the former chief executive of GRAD Associates, P.A., a Newark architectural...
In the October 2016 issue of New Jersey Business, Walsh was one of four firms profiled for "notable diversity initiatives and profiles." The article quotes extensively from founding partner Liza M. Walsh, who explained: “Support for women and minorities was hard-wired into our organization from inception." For more...
On Wednesday, September 21st, Walsh Pizzi clients, Pfizer, Inc., Valeant Pharmaceuticals International, Bausch & Lomb, Inc., and Aton Pharma, Inc., along with others urged the Third Circuit not to revive the litigation accusing them of boosting prescription eye drop sales by using bottles that dispensed...
On September 9, 2016, Walsh's Joseph L. Linares was named President-Elect of the Young Lawyers Division of the Hispanic National Bar Association at the organization's Annual Convention in Chicago, Illinois. In his new post, Mr. Linares will oversee YLD groups within HNBA’s 19 Regions and also will hold a seat...
On September 14, 2016, the New Jersey Law Journal announced the 2016 Top Women in Law and named Walsh founder Liza M. Walsh to the list. The full article is available. The Law Journal met with Liza as part of her recognition. The interview is available....
On August 25, 2016, a sign was installed in the firm's Newark office. Another milestone! ...
The New York Times on August 23, 2016, wrote an investigative piece about Governor Andrew Cuomo's efforts to develop a high-tech film studio in upstate New York (pictured below from the Times article), focusing in part upon the involvement of Ryan R. Johnson in the project. The article...
NetJets Inc., a Walsh client, has sued three founders of Phoenix Star Capital, a failed investment firm, seeking to collect on amounts due for private aviation services. The suit has garnered attention in Forbes. The full piece is available here. For more information about the firm’s...
Gilead Sciences Inc. and Emory University, represented by Liza M. Walsh and Eleonore Ofosu-Antwi, have accused Indian drugmaker Hetero Drugs Ltd. of infringing four patents protecting Truvada®, Gilead's commercially successful HIV treatment. Read Full Article Here ›...
Quaker Oats to Fight Syrup Claims in Cali Read Full Article Here >...